• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Healthcare·UNVC
Share

Univec, Inc. Stocks

$ 0Last Updated 28.07.2026

Issuer Rating

3/7
Performance

Average

Risk

High

Recommendation

Sell

Market Cap

$ 8.33M

$ 0
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Univec, Inc. is a medical device firm that, through its various operating divisions, develops, licenses, and sells products across the United States and internationally. Its primary offerings include a range of auto-disable and safety syringes. These encompass 1cc AD-syringes, which can be used for both aspirating and non-aspirating procedures, typically for dispensing precise doses of allergy, immunization, and insulin medications. Univec also produces sliding sheath syringes, engineered to protect both patients and healthcare professionals from accidental needlestick injuries. Additionally, the company manufactures bifurcated needle safety syringes, specifically designed for administering smallpox vaccines, particularly in response to potential bioterrorist threats. Univec distributes its auto-disable and sliding sheath safety syringes to private hospitals, other healthcare facilities, and distributors within the U.S., as well as to governmental entities in developing countries. Furthermore, it offers an online system that assists pharmaceutical companies with the marketing, fulfillment, and tracking of drug samples, serving as a connector between pharmacies and managed payment providers. The company was founded in 1992 and is based in Baltimore, Maryland.

Company Valuation

Fairly valued
4/7

Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. Specifically, the stock is fairly valued on P/E.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

30.07.2026 21:41

Amazon's AI spending has spiraled out of control, and the company is now trying to rein it in — FT

30.07.2026 21:41

Adidas shares plummeted at a record pace. What does the World Cup have to do with this?

30.07.2026 21:00

"Protection Against AI on Wall Street": What the Market Expects from Apple's Report

30.07.2026 20:09

Meta Lost $100 Billion in Market Value Amid Zuckerberg's Attempts to Sell an AI Concept

30.07.2026 19:30

"Volatility Is the New Normal": Shell Posts Second-Highest Profit in Its History

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026